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Abstract. Most countries have developed information systems to report drug 
adverse effects. However, as in other domains where systematic reviews are 
needed, there is little guidance on how systematic documentation of drug adverse 
effects should be performed. The objective of the VigiTermes project is to develop 
a platform to improve documentation of pharmacovigilance case reports for the 
pharmaceutical industry and regulatory authorities. In order to improve systematic 
reviews of adverse drug reactions, we developed a prototype that first reproduces 
and standardizes search strategies, then extracts information from the Medline 
abstracts which were retrieved and annotates them. The platform aims at providing 
transparent access and analysis tools to pharmacovigilance experts investigating 
relevance of safety signals related to drugs. The platform’s architecture consists in 
the integration of two vendor tools ITM® and Luxid® and one academic web 
service for knowledge extraction from medical literature. Whereas a manual search 
performed by a pharmacovigilance expert retrieved 578 publications, the system 
proposed a list of 229 publications thus decreasing time required for review by 
60%. Recall was 70% and additional developments are required in order to 
improve exhaustivity. 
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1. Introduction 
The information about drug safety is based mainly on spontaneous reporting systems 
by health care professionals to a central agency and/or to the pharmaceutical companies 
[1]. Other sources of information are of interest to improve our knowledge of adverse 
drug reaction. The medical literature is one of them, and its analysis is mandatory for 
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the pharmaceutical companies, as noted in the recent Guidelines on Pharmacovigilance 
for medicinal products for human use. “The Marketing Authorisation Holder is 
therefore expected to maintain awareness of possible publications by accessing a 
widely used systematic literature review and reference database (e.g., Medline, 
Excerpta Medica or Embase) no less frequently than once a week” [2]. 
Currently, with widespread use of internet, information retrieval, extraction and 
analysis of individual cases reports, or of other information (clinical studies, 
epidemiological studies, press releases, …), is a challenge for pharmacovigilants [3]. 
Several studies showed that researchers reported difficulties when searching electronic 
resources for information on adverse effects [4–6]. Among others, these difficulties are 
due to poor indexing, to the wide variety of articles that may be potentially useful, to 
variation in their qualities, as well as the lack of tools to perform systematic search. 
Moreover, the field of pharmacovigilance is extensive as all drugs and all adverse 
events must be under surveillance. The question and/or the answer about safety may be 
broad or narrow in scope. For example, a review with a broad scope might be “which 
adverse effects are associated with antidepressant therapy” and a narrow one being 
“the risk of suicide or suicidal behavior in teens taking a serotonin reuptake inhibitor”. 
Adverse Drug Reaction (ADR) reviews may be appropriate targets for clustering 
techniques and require complex literature search strategies, as well as information 
extraction driven by domain knowledge. Therefore, it is desirable to develop a 
literature search strategy based on key elements of the pharmacovigilance field, to 
automate data mining in electronic databases, to have a better information retrieval and 
to assist the pharmacovigilance specialist visualizing and mining the results. 
Automation is one of the very important requirements, as it is needed to ease the 
knowledge acquisition bottleneck, particularly for annotating large collections of 
legacy documents [7]. 
In this article, we present for the first time the design of a new platform that 
automatically performs searches and identifies information on adverse drug reactions 
from the medical literature, as part of the VigiTermes project (http://vigitermes.univ-
rennes1.fr). 
2. Material and Methods 
The architecture of the system is based on an integrated platform composed of both 
existing and specifically developed web services. When a new case is reported, the 
workflow consists of three main steps (i) to build and refine a normalised query to 
retrieve pertinent abstracts from Medline, (ii) to perform domain-oriented annotation 
on Medline abstracts and (iii) to enrich the knowledge base and the documentation of 
the case report. The steps are encapsulated in a UIMA [11] (Unstructured Information 
Management Architecture) infrastructure, providing a rich text mining standardized 
environment for manipulating documents and annotations, and easing external 
components integration, being the ones presented in this article or others. Also, the 
UIMA infrastructure has been enriched to comply with the Semantic Web standards, so 
that the outputs can be easily accessed, shared and exploited by other applications. 
 
Pubmed Querying Web Service  
We reused and adapted the algorithm developed by Garcelon et al. for querying 
Medline [8]. The main entry is a pair of Adverse Effect (AE) – Active Ingredient (AI). 
Additional parameters may be added for filtering purposes, such as gender, age class, 
publication type and period. The web service relies on a UMLS web service to 
normalize the entries [9] and the MEDLINE web service to retrieve the corresponding 
abstracts [10]. 
 
Luxid® Annotation Factory 
Luxid® Annotation Factory (LAF) is a software component dedicated to information 
extraction: It takes as input original documents and enriches them with semantic 
annotations (categories, entities and relationships). All analysis steps are packaged in 
linguistics components that build a so-called Skill Cartridge, which is plugged to the 
extraction server. It can be imagined as a cascade of extraction modules that condense 
the textual data into meaning. The analysis is based on finite state technology. A 
specific Skill Cartridge™ dedicated to pharmacovigilance has been defined, extracting 
medical entities (Diseases, Treatments, Diagnostic Methods, Symptoms, Patients, 
Clinical trials) as well as relationships (Diagnosis, Therapy, Drug use such as doses, 
route, frequency and duration). 
 
Intelligent Topic Manager 
The Intelligent Topic Manager® (ITM) [11] is an ontology-based solution for 
Taxonomy, Thesaurus, Controlled vocabulary and Knowledge base Management based 
on the Semantic Web standards (RDF, OWL, SKOS). It allows access to distributed 
knowledge, management of large terminologies and collaborative and customized 
access for end users to legacy content through semantic portals. ITM uses MedDRA or 
the WHO-ART terminologies to consolidate and enrich the annotations and exploit 
them to automatically create new instances in the knowledge base such as the detected 
relations between adverse effects and drugs. This is operated by the ITM’s Content 
Augmentation Manager (CA Manager), an open-source tool that is used to bridge the 
gap between information extraction tools and semantic repositories and that extends the 
UIMA framework with the Semantic Web standards. 
3. Result 
The VigiTermes solution for the semantic annotation of pharmacovigilance-related 
articles is a semantic portal that performs: 1) automated extraction and annotation of 
Medline abstracts with regard to a pharmacovigilance ontology and standard medical 
terminologies, and 2) case reports documentation thanks to the knowledge instances 
detected from the produced annotations. The semantic portal provides a user interface 
from which the pharmacovigilance expert submits a query with at least one AE and one 
AI as reported in the case. The platform then calls the web service that translates and 
enriches the user query in order to obtain a list of relevant PMIDs from Pubmed. This 
list of PMIDs is then sent to the CA Manager (see Figure 1) that transmits the abstract 
content of each PMID to Luxid® which extracts the relevant information and annotates 
it. This enriched content is then controlled by the CA Manager with respect to the 
medical terminologies and the knowledge base instances already stored in ITM. It 
consolidates each annotation and new knowledge instance thanks to a set of heuristic 
rules detailed in [12] before sending back the results to the semantic portal. The 
visualization step takes advantage of the produced annotations by highlighting the 
relevant concepts and instances identified in the abstracts. 
  
Figure 1. Case report documentation workflow 
 
As of today, the pharmacovigilance regional centre of the European Georges 
Pompidou hospital experiments the VigiTermes semantic portal for functional 
validation. Use case is the documentation process for new ADR-AI case reports. 
Preliminary results have been obtained for the Pubmed Query web service. The gold 
standard was a Medline search performed by a pharmacovigilant expert who recorded 
his queries and identified the relevant publications based on 15 reported ADR cases. 
These relevant references represented 69 publications selected from the 578 retrieved 
with the Medline search (12%). The Pubmed Query component was then applied to the 
same set of 15 cases and the number of identified publications was 229. Within this set, 
48 publications were belonging to the 69 relevant publications selected by the 
pharmacovigilance expert. Recall was 70% and precision 21%. Eleven cases of 15 have 
a recall of 100%. 
4. Discussion and Conclusion 
The medical literature is still a major source of information to evaluate drug safety: It 
has a valuable role in providing early warning alerts and can strengthen a signal 
detected by other means. Whereas pharmaceutical companies must organise a 
systematic survey only for the drugs they commercialize, regulatory authorities have to 
screen all the drugs available on the market. In any case, the amount of published 
literature on ADRs is overwhelming, so a standardized and automated tool would 
ensure that a minimum surveillance could be performed for each drug. The national 
French VigiTermes research project was funded to implement new methods for signal 
detection and analysis in pharmacovigilance. We presented the integration platform 
built to support the pharmacovigilance teams from industry and regulatory authorities 
by standardizing literature search on ADRs. The system works as a filter and it is able 
to reduce the number of abstracts to be reviewed by 60%. Additional developments are 
required in order to improve recall. The technical choices are based on Semantic Web 
technologies, including ontology development and Web services, and the new 
standards recently developed in Natural Language Processing (UIMA).  
Knowledge-based approaches have already been developed for screening drugs 
and predicting drug safety at the pre-clinical stage whereas this knowledge 
management platform is dedicated to the documentation of spontaneous case reports 
after market authorization. The development perspectives of our project will aim at 
adding other pharmacovigilance-related data sources (such as Martindale, Meyler’s 
Side effects of Drugs, other databases like Micromedex) in order to complete data 
obtained from Pubmed. The presented platform can also be improved by developing 
tailored user interfaces for the pharmacovigilance end user. Moreover, to tackle some 
actual limitations of the platform, ontologies like SNOMED CT, by offering the ability 
to relate concepts together, will be most valuable in order to build clusters of MedDRA 
terms that express similar medical conditions. The PharmARTS tool developed by 
another partner of the VigiTermes project implements mappings between SNOMED 
CT and MedDRA/WHO-ART and a web-based graphical interface in order to select 
adverse reaction terms corresponding to a formal definition expressed thanks to 
SNOMED CT concepts [13]. This would help to complement the current search 
strategy by adding subsumption mechanisms in the algorithm. Finally the platform 
should accommodate cross-platform integration with proprietary spontaneous reporting 
system or other signal detection tools. 
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